Organisation: Cape Bio Technologies (Pty) Ltd
Designation: Chief Executive Officer
Title of the presentation: “Leveraging Fourth Industrial Revolution Tools to Leapfrog IKS Advancements”.

Mr. Daniel Ndima is a scientist who specializes in structural biology of infectious diseases. He is trained in protein engineering and crystallography, bioprocess engineering and biomanufacturing. He has a Bachelor & Honours degrees in Biotechnology (University of the Western Cape) and a Masters degree in Structural Biology of infectious diseases) from University of Pretoria. Throughout his academic journey, he was awarded multiple awards and scholarships for his excellence in academics, social responsibility, student leadership, and entrepreneurial initiatives. He is a fellow at Allan Gray Orbis Foundation. This Fellowship provides WEBINAR The Role of Traditional Medicine in Modern Healthcare Systems education beyond a degree, offering 360 degrees of entrepreneurial training to ensure that Fellows create value through responsible entrepreneurship, see entrepreneurship as a viable career path, are able to take an idea and develop it into a viable opportunity. Daniel is a Scholar at Mandela Rhodes Foundation (Class of 2015). He is also a Brightest Young Minds (BYM2016) Alumnus. He founded 3 (three) star-ups as an undergraduate student and was subsequently awarded the Vice Chancellor’s Award.

In 2020, he was listed as one of African Influencers for Change by UNDP Africa. A careers1825 Role Model and featured on Africa Innovates Magazine. He participated in various panel discussions on Pandemics including the South African National Coronavirus Conference chaired by Minister of Science and Innovation – with the President and WHO Director as some of the speakers. He participated in United Nations’ dialogue on African Readiness to combat COVID-19. He is a Mail & Guardian Top 200 South African 2021 Winner under Science and Technology category. Daniel strongly advocates for science that creates jobs, improve quality of ordinary lives, contributes to national development and the economy. Daniel has worked at the Council for Scientific and Industrial Research (CSIR) towards the commercialization of technologies as a technologist and business developer for CapeBio project.

Daniel is the Founder and CEO of CapeBio Technologies (CapeBio), a South African biotech company that manufacturers molecular biology reagents, enzymes and kits for diagnostics, forensic DNA analysis and other life science applications. CapeBio recently developed a SAHPRA approved PCR testing kit for the Coronavirus detection and expanding its diagnostics research, development and manufacturing for diseases prone to Africa – and the world.